SPHERICAL CRYSTALLIZATION A NOVEL APPROACH FOR SOLUBILITY AND DISSOLUTION ENHANCEMENT OF SIMVASTATIN
DOI:
https://doi.org/10.22159/ajpcr.2016.v9i6.13420Abstract
Simvastatin is commonly used antihyperlipidemic in the treatment of hypercholesterolemia and dyslipidemia. As evidenced form the scientific investigation, it is reported for its lower solubility and poor dissolution rate. The aim of the present investigation was to develop simvastatin spherical agglomerates to improve its solubility and dissolution characteristics by spherical agglomeration method. The crystallization media used was methanol, water and chloroform as bridging liquid and PVP K-30 as a polymer. The process variables such as amount and type of (bridging liquid and polymer), stirring speed and stirring time were optimized and reported. The spherical agglomerates were further subjected for determination of % drug content, particle size analysis, solubility and dissolution rate. The agglomerates were also characterized by Differential Scanning Calorimetry (DSC), Fourier Transform Infrared Spectroscopy (FTIR), and X-ray Powder Diffraction (XRD) analysis and affirmed. Among the entire parameters spherical agglomerates obtained with methanol (7ml), water (50ml), chloroform (1.5ml) and PVP K-30 (0.5%) showed improvement in solubility and dissolution rate in comparison with pure drug. The spherical agglomerates showed significant improvement in dissolution from a value of 25.53% for pure simvastatin to 91.31% of spherical agglomerate. The spherical agglomerates of optimized batch were directly compressed and dissolution profile was compared with marketed tablet. Such a technique can successfully be employed to improve solubility and dissolution characteristic of poorly soluble drugs.
Downloads
References
Chauhan N., Satapara V., Sorathiya K., Parmar K., Raval M. and Patel P., Spherical crystallization: An aspect to increase the pysicochemical properties of drugs, International journal of pharmaceutical innovations 2012 ; 2(4): 37-47.
Kumar S, Chawla G, Bansal AK, Spherical crystallization of mebendazole to improve processability, Pharmaceutical Development and Technology 2008; 13(6): 559-568.
Ambike A., Mahadik K., Paradkar A., Spray- dried amorphous solid dispersions of simvastatin a low tg drug; in vitro and in vivo evaluations. Pharmaceutical Research 2005; 22(6): 990–998.
Cheng H., Sutton S., Pipikin J., Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl coenzyme a (HMG-coA) reductase inhibitor in dogs and humans. Pharmaceutical resaerch, 1993; 10(11): 683–687.
Mcclelland C., Stubbs R., Fix J., Pogany S., Zentner G., Enhancement of 3- hydroxy-3- methylglutaryl-coenzyme a (HMGcoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form., Pharmaceutical Research 1991; 8(7): 873–876.
Dixit, R. P., Nagarsenker M. S., In vitro and in vivo advantage of celecoxib surface solid dispersion and dosage form development. International Journal Pharmaceutical Science 2007; 69(3): 370–377.
Katta J., Ake C. Rasmuson., Spherical crystallization of benzoic acid. International Journal of Pharmaceutics 2008; 348: 61–69
Gupta V R., Formulation and evaluation of directly compressible agglomerates of Celecoxib, International Journal of Pharmaceutical Sciences and Nanotechnology 2011; 3(4): 1193-1204.
Nandgude T.D, Bhise K.S, Gupta V.B. Characterization of Hydrochloride and Tannate Salts of Diphenhydramine. Indian Journal of Pharmaceutical Science 2008, 483-487.
Gohle M.C, Parikh R.K, Shen H, Improvement in flowability and compressibility of Ampicilline Trihydrate by spherical crystallization, Indian Journal of Pharmaceutical Science 2003; 6(13): 634-637.
Yadav V. B., Yadav A.V., Designing of pharmaceuticals to improve physicochemical properties by spherical crystallization technique, Journal of Pharmacy Research 2008;1(2):105-112.
Ueda M., Nakamura Y., Makita H., Imasato Y., Kawashima Y., Particle design of Enoxacin by spherical crystallization technique II, Characteristics of agglomerated crystals, Chem. Pharm. Bull 1991;39(5):1277-1281.
Thenge R. R., Crystal Modification of Aceclofenac by Spherical Crystallization to Improve Solubility Dissolution Rate and Micromeritic Properties, Journal of Pharmacy Research 2011;5(2):974-977
Fatima S. and Jamil S., Effect of surfactant on dissolution of simvastatin tablets; comparison with usp, World journal of pharmacy and pharmaceutical sciences, 3(3), 142-150.
Srinu R., Krishna M., K.V.S. Prasada Rao, Formulation and evaluation of fast dissolving tablets of simvastatin using novelco-processed superdisintegrants, Scholars Academic Journal of Pharmacy (SAJP) 2003;2(4):340-353.
Rajaiya P., Mishra R.K., Nandgude T.D., Poddar S., Solubility and Dissolution Enhancement of Albendazole by Spherical Crystallization, Asian Journal of Biomedical and Pharmaceutical Sciences, 2016; 6(52), 09-14.
Mishra R.K., Nandgude T.D., Spherical Crystallization for Solubility and Dissolution Enhancement of Meloxicam by Neutralization Method, Inventi Impact: Pharmaceutical Process Development, 2016; (2), 1-8.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
